Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Health Topics: Page 4
Study: Blood test improves bipolar disorder diagnosis through biomarkers
By
Matt Limb
Diagnosis of bipolar disorder could be improved using a simple blood test to identify biomarkers associated with the condition, say researchers.
November 2, 2023
Oxford Nanopore partners with Fabric Genomics on assessment of genetic disease in children
By
Nick Paul Taylor
Oxford Nanopore Technologies and Fabric Genomics have teamed up to provide a sequencing analysis platform for neonatal and pediatric intensive care units.
November 1, 2023
Vertex Pharmaceuticals, CRISPR Therapeutics gene-editing therapy to undergo FDA advisory committee review
By
LabPulse.com staff writers
An FDA advisory committee is scheduled to meet on October 31 to discuss and make recommendations on Vertex Pharmaceuticals' and CRISPR Therapeutics’ CRISPR-Cas9 gene-editing-based therapy, exagamglogene autotemcel.
October 30, 2023
Study: Proteomic profiling used to track effects of aging, diseases on the eyes
By
LabPulse.com staff writers
In a study published in
Cell
, researchers used proteomic profiling and artificial intelligence (AI) modeling to determine biomarkers and track the progression and effects of aging and disease on the eyes.
October 24, 2023
Researchers use motor sensors, machine learning to track Parkinson’s progression
By
Matt Limb
Scientists say they have used data derived from sensors worn by patients and machine-learning analysis to accurately track the progression of Parkinson’s disease.
October 19, 2023
CMS opens new doors for cell and gene therapy under Medicaid
By
Liz Carey
A new Medicaid-focused Innovation Center model encourages agreements between pharmaceutical companies and states for cell and gene therapies (CGT).
October 18, 2023
AI-driven method developed to identify therapeutic targets
By
Matt Limb
Researchers have developed a method of identifying therapeutic targets for human diseases associated with protein phase separation that they say could be used to discover targets for Alzheimer’s and other neurogenerative diseases.
October 17, 2023
U.K. researchers recommend routine diabetes screening in EDs
By
Matt Limb
Diabetes screening should be introduced for patients attending hospital emergency departments (EDs) to prompt earlier treatment where necessary and reduce major health risks, say researchers.
October 10, 2023
Protein panel improves Alzheimer’s diagnosis, predictions of disease progression
By
Nick Paul Taylor
Quantifying certain proteins in cerebrospinal fluid could improve the diagnosis of Alzheimer's disease and prediction of disease progression, according to a paper in Science Translational Medicine.
October 3, 2023
Genetic predisposition to smoking may drive schizophrenia heart disease risk: Study
By
Nick Paul Taylor
Genetic factors are unlikely to directly drive the increased rate of cardiovascular disease in schizophrenia patients but may influence lifestyle, according to a paper in the American Journal of Psychiatry.
September 29, 2023
Alzheimer’s drug approval poised to reshape APOE testing market
By
Nick Paul Taylor
The U.S. Food and Drug Administration (FDA) approval of Biogen and Eisai’s Alzheimer’s disease drug Leqembi is likely to drive changes in the APOE testing market, according to an article in GenomeWeb.
September 25, 2023
Protein biomarker may aid in early Parkinsonian disorders detection
By
LabPulse.com staff writers
A protein biomarker present in cerebrospinal fluid and blood plasma may be useful for the early diagnosis of Parkinsonian disorders.
September 21, 2023
Previous Page
Page 4 of 69
Next Page